California legislative agenda & upcoming votes California session calendar
Summary
Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law prohibits a pharmacy benefit manager from discriminating against a covered entity or its pharmacy in connection with dispensing a drug subject to federal pricing requirements or preventing a covered entity from retaining the benefit of discounted pricing for those drugs.
This bill would prohibit a prescription drug manufacturer from engaging in discriminatory practices that would impose additional conditions, prohibit, restrict, deny, or interfere with a qualifying nonhospital 340B community clinic's purchase or delivery of a drug subject to federal pricing requirements if the qualifying nonhospital 340B community clinic utilizes a specified pharmacy, including a contract pharmacy, that dispenses the drug to an eligible patient of the qualifying nonhospital 340B community clinic. The bill would define "discriminatory practices" and "qualifying nonhospital 340B community clinic" for these purposes. The bill would require qualifying nonhospital 340B community clinics to annually perform specified activities to ensure compliance with program rules and guidance from the federal Health Resources and Services Administration. The bill would make related intent statements.
- AB 1460 is a bill in the California Assembly, 20252026 session, introduced February 21, 2025.
- Current status: passed one chamber.
- Most recent action (July 16, 2025): In committee: Hearing postponed by committee.
- 2 recorded votes; the most recent, on May 19, 2025, passed 44-6.
- Subjects: Prescriptiondrugpricing.
Contact your legislator about this bill
Bill text & documents
- AB1460 (opens in a new tab)
- 02/21/25 - Introduced (opens in a new tab)
- 04/24/25 - Amended Assembly (opens in a new tab)
- 06/27/25 - Amended Senate (opens in a new tab)
- 04/18/25- Assembly Health (opens in a new tab)
- 04/30/25- ASSEMBLY FLOOR ANALYSIS (opens in a new tab)
- 07/14/25- Senate Health (opens in a new tab)
- This bill on Open States (opens in a new tab)
Sponsors
History
- Introduced, completed
- Passed Assembly, completed
- Passed Senate, in progress
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Assembly Introduced. To print. Milestone
- Assembly From printer. May be heard in committee March 24.
- Assembly Read first time.
- Assembly Referred to Com. on HEALTH.
-
Assembly
Do pass as amended.
9 yes 4 no, 3 other Passed, 69% yes
- Assembly From committee: Amend, and do pass as amended. (Ayes 9. Noes 4.) (April 22).
- Assembly Read second time and amended. Ordered returned to second reading.
- Assembly Read second time. Ordered to third reading.
-
Assembly
Read third time. Passed. Ordered to the Senate. (Ayes 44. Noes 6. Page 1589.)
Milestone
AB 1460 Rogers Assembly Third Reading: 44 yes 6 no, 29 other Passed, 88% yes
- Senate In Senate. Read first time. To Com. on RLS. for assignment.
- Senate Referred to Com. on HEALTH.
- Senate In committee: Set, first hearing. Hearing canceled at the request of author.
- Senate From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
- Senate In committee: Set, second hearing. Hearing canceled at the request of author.
- Senate In committee: Hearing postponed by committee. Latest